Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017.

Ming LiBoyang ZhouLihong ZhouLin-Feng Li

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

There are a lot of circulating CPMs with the indication for eczema in mainland China, but both the quantity and the reporting quality of RCTs regarding those CPMs are suboptimal. It is necessary that authors and journal editors learn and adhere to the CONSORT-CHM formulas 2017 to enhance the reporting quality of RCTs for the treatment of eczema with CPM.

Keyphrases

adverse drug
atopic dermatitis
quality improvement
emergency department
combination therapy
electronic health record